Mark R Walter
University of Alabama at Birmingham
H-index: 45
North America-United States
Top articles of Mark R Walter
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cmv vectors and uses thereof | 2024/1/11 | ||
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN. 1 and other variants | bioRxiv | Michael S Piepenbrink Ahmed Magdy Khalil Ana Chang Ahmed Mostafa Madhubanti Basu | 2024 |
Role of DOCK8 in Hyper-inflammatory Syndromes | medRxiv | Mingce Zhang Remy R Cron Niansheng Chu Junior Nguyen Scott M Gordon | 2024 |
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology | Nature communications | Daniel N Streblow Alec J Hirsch Jeffrey J Stanton Anne D Lewis Lois Colgin | 2023/11/3 |
Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses | The FEBS Journal | Ashlesha Deshpande Nobert Schormann Mike S Piepenbrink Luis Martinez Sobrido James J Kobie | 2023/7 |
Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission | Microbiology spectrum | Chengjin Ye Jun-Gyu Park Kevin Chiem Piyush Dravid Anna Allué-Guardia | 2023/6/15 |
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody | PLoS Pathogens | Michael S Piepenbrink Jun-Gyu Park Ashlesha Deshpande Andreas Loos Chengjin Ye | 2022/7/21 |
Methods and compositions for il10 signaling antagonism | 2022/5/12 | ||
Pan-coronavirus neutralizing S2 human monoclonal antibodies and utility of direct respiratory administration as combination therapy with S1 antibodies against SARS-CoV-2 | The Journal of Immunology | James Kobie Jun-Gyu Park Sanghita Sarkar Madhubanti Basu Andreas Loos | 2022/5/1 |
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody | bioRxiv | Michael S Piepenbrink Jun-Gyu Park Ashlesha Desphande Andreas Loos Chengjin Ye | 2022/3/7 |
Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membrane | Cell reports methods | Junel Sotolongo Bellón Oliver Birkholz Christian P Richter Florian Eull Hella Kenneweg | 2022/2/28 |
Monitoring SARS-CoV-2 infection using a double reporter-expressing virus | Microbiology Spectrum | Kevin Chiem Jun-Gyu Park Desarey Morales Vasquez Richard K Plemper Jordi B Torrelles | 2022/10/26 |
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes | Journal of virology | Kevin Chiem Desarey Morales Vasquez Jun-Gyu Park Roy Neal Platt Tim Anderson | 2021/3/10 |
Structures, Signaling Mechanisms, and Functions of Types I and III Interferons | Frontiers in Immunology | Ronald L Rabin Mark R Walter | 2021/2/18 |
Visualization of SARS-CoV-2 infection dynamic (preprint) | Chengjin Ye Kevin Chiem Jun-Gyu Park Jesus Silvas Desarey Morales Vasquez | 2021 | |
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2 | Journal of Virological Methods | Jun-Gyu Park Fatai S Oladunni Kevin Chiem Chengjin Ye Michael Pipenbrink | 2021/1/1 |
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of virology | Kevin Chiem Desarey Morales Vasquez Jesus A Silvas Jun-Gyu Park Michael S Piepenbrink | 2021/10/27 |
Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses | Proceedings of the National Academy of Sciences | Chengjin Ye Kevin Chiem Jun-Gyu Park Jesus A Silvas Desarey Morales Vasquez | 2021/10/12 |
Visualization of SARS-CoV-2 infection dynamic | bioRxiv | Chengjin Ye Kevin Chiem Jun-Gyu Park Jesus A Silvas Desarey Morales Vasquez | 2021/6/4 |
Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern | Frontiers in immunology | Ashlesha Deshpande Bethany D Harris Luis Martinez-Sobrido James J Kobie Mark R Walter | 2021/6/4 |
